At a glance
The Clinical Laboratory Improvement Advisory Committee (CLIAC) provides guidance to the Department of Health and Human Services (HHS). The advice and guidance CLIAC provides to HHS pertains to general issues related to improvement in clinical laboratory quality and laboratory medicine practice.
About
The Clinical Laboratory Improvement Advisory Committee (CLIAC) is managed by the Centers for Disease Control and Prevention (CDC). CLIAC provides scientific and technical advice to the Department of Health and Human Services (HHS).
Impact
CLIAC advises HHS on improving clinical laboratory quality and laboratory medicine practice. The Committee also offers guidance on revising Clinical Laboratory Improvement Amendments (CLIA) standards.
Members
The Committee has a consumer representative and has diverse membership across:
- Laboratory specialties.
- Professional roles: laboratory management, technical, physicians, nurses.
- Practice settings: academic, clinical, public health.
The clinical and anatomic pathology laboratory specialties represented include:
- Microbiology
- Immunology
- Chemistry
- Hematology
- Immunohematology
- Cytopathology
- Histopathology
- Genetic testing
- Informatics
The Committee also includes three ex officio members from the federal agencies that oversee the CLIA program, specifically the:
A nonvoting liaison representing the laboratory industry participates on the Committee.
Who to contact
For agenda topic suggestions, nomination information, or additional questions related to CLIAC, please contact CLIAC@cdc.gov.